Pharmafile Logo

HSCIC

- PMLiVE

Mylan sees the UK paving the way for an insulin game changer

As biosimilars surge into the insulin market, governments  are urged to seize ‘the opportunity of the century’

- PMLiVE

Novo’s diabetes pill defeats Merck’s Januvia in trial

Oral semaglutide also outshines its best-selling diabetes injectable Victoza

30 Women Leaders in UK Healthcare (part 3)

Continuing our special feature on Women Leaders in UK Healthcare

- PMLiVE

NHS could save £7bn with greater diagnostics use

Report suggests IVD tests could be key to big savings

- PMLiVE

How can pharma build bridges with HCPs online?

Simon Grime, Director of Fendix, explains how pharma can reconnect with disillusioned doctors and other HCPs

- PMLiVE

NICE set to reject Kyowa Kirin’s Crysvita for XLH

Committee says the rare disease therapy isn’t value for money

- PMLiVE

Daily Brief: BIO takes over from ASCO, Greece’s Novartis bribery case and more

Highlights from the world of pharma, biotech and healthcare

- PMLiVE

NICE backs Tesaro’s Zejula via the CDF

Recommends the drug for second-line use in ovarian cancer patients

- PMLiVE

Patient outcomes in practice: delivering value that transforms lives

Over the next five years, the NHS needs to drive efficiencies of £22bn. Like all global healthcare systems, it faces the challenge of improving the health of larger and older...

Improving NHS sustainability through service redesign partnerships and effective communications

With year-on-year increases in demand and the imperative to reduce its deficits, the NHS must look beyond merely doing more of the same if it is to become sustainable. Never...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links